A 2024-2025 tour of migraine drug research
A digest of 2024-2025 migraine drug research spanning CGRP therapies, a dual-target compound, nerve blocks, gut microbiota links, and placebo response rates.
Related
A Curated Reading List on Exercise and Cancer Treatment
A collection of reviews, meta-analyses, and trials on how exercise affects cancer risk, treatment side effects, and recovery outcomes across cancer types.
The 400 IU prenatal vitamin D figure is now outdated
A comparison of vitamin D across prenatal brands shows the oft-cited 400 IU figure is outdated, with today's best-sellers running two to four times higher.
Tiering twelve VDR-activating supplements for glaucoma evidence
A tiered evidence review of glaucoma supplements, separating the two backed by real human trial data from a long list resting on little more than mechanism.
Which countries actually give vaccine makers legal immunity
A breakdown of which countries shield vaccine makers from lawsuits versus the more common no-fault programs that compensate injury without assigning blame.